Exercise in inflammatory myopathies, including inclusion body myositis

Current Rheumatology Reports

Volumn 14, Issue 3, 2012, Pages 244-251

  Alexanderson, Helene ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aerobic exercise; Dermatomyositis; Exercise; Inclusion body myositis; Inflammatory myopathy; Juvenile dermatomyositis; Muscle function; Muscle impairment; Muscle weakness; Polymyositis; Resistance training

Indexed keywords

CREATININE; PLACEBO;

AEROBIC EXERCISE; ANXIETY; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ACTIVITY; EXERCISE; HUMAN; INCLUSION BODY MYOSITIS; INFLAMMATION; JUVENILE DERMATOMYOSITIS; LOADING DRUG DOSE; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; QUALITY OF LIFE; RESISTANCE TRAINING; REVIEW;

DERMATOMYOSITIS; EXERCISE; HUMANS; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS;

EID: 84860765052     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-012-0248-4     Document Type: Review

References (47)

1. Hengstman GJ, van den Hoogen FH, van Engelen BG. Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother. 2009;10:1183-90.
2. Harris-Love MO, et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford). 2009;48:134-9.
3. Regardt M, et al. Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study. Rheumatology (Oxford). 2011;50:578-85.
4. Alexanderson H, et al. Functional index 2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 2006;55:114-22. (Pubitemid 43235135)
5. Fathi M, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004;63:297-301. (Pubitemid 38250674)
6. Wiesinger GF, et al. Aerobic capacity in adult dermatomyositis/ polymyositis patients and healthy controls. Arch Phys Med Rehabil. 2000;81:1-5. (Pubitemid 30036865)
7. Ponyi A, et al. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford). 2005;44:83-8. (Pubitemid 40124337)
8. Nyberg P, et al. Increased expression of interleukin 1 alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol. 2000;27:940-8. (Pubitemid 30389751)
9. Englund P, et al. Interleukin-1 alpha expression in capillaries and major histocompatability complex I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum. 2002;46:1044-55. (Pubitemid 34303818)
10. Cea G, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31p-magnetic resonance spectroscopy and MRI-study. Brain. 2002;125:1635-45. (Pubitemid 34755177)
11. Park JH, et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum. 1995;38:68-77.
12. Askanas V, Engel WK. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol. 2007;19:550-9. (Pubitemid 47530874)
13. Lindberg C, Oldfors A. Prognosis and prognostic factors in sporadic inclusion body myositis. Acta Neurol Scand. 2011. doi:10.1111/j.1600-0404.2011. 01584.x.
14. Sadjadi R, et al. What determines quality of life in inclusion body myositis. J Neurol Neurosurg Psychiatry. 2011;81:1164-6.
15. Wedderburn L, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol. 2009;5:665-78.
16. Sanner H, et al. Longterm muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study. Arthritis Care Res. 2010;62:1103-11.
17. Drinkard BE, et al. Fitness as a determinant of the oxygen uptake/ work rate slope in healthy children and children with inflammatory myopathy. Can J Appl Physiol. 2003;28:888-97. (Pubitemid 38019352)
18. Hicks JE, et al. Decreased aerobic capacity in children with dermatomyositis. Arthritis Rheum. 2002;47:118-23. (Pubitemid 34303837)
19. Butbul Aviel Y, et al. Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology (Oxford). 2011;50:2051-60.
20. Habers GA, Takken T. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy- a systematic review. Rheumatology (Oxford). 2011;50:2113-24.
21. Spector SA, et al. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve. 1997;20:1242-8. (Pubitemid 27415512)
22. Arnardottir S, et al. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program in muscle function, histopathology and inflammatory reaction. J Rehabil Med. 2003;35:31-5. (Pubitemid 36204070)
23. Harris-Love M. Safety and efficacy of submaximal eccentric strength training for a subject with polymyositis. Arthritis Rheum. 2005;53:471-4. (Pubitemid 40799890)
24. • Gualano B, et al. Resistance training with vascular occlusion in inclusion body myositis: a case study. Med Sci Sports Exerc. 2010;42:250-4. This case report describes improved quadriceps function following a 52-week submaximal exercise program during vascular occlusion.
25. Johnson GL, et al. The effectiveness of an individualized, home-based functional exercise program for patients with sporadic inclusion body myositis. Clin Neuromusc Dis. 2007;8:187-94.
26. • Johnson LG, et al. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis. Clin Neuromusc Dis. 2009;10:178-84. This was the first study to evaluate aerobic exercise in inclusion body myositis, suggesting improved aerobic capacity and muscle function.
27. Jeppesen TD, Olsen D, Vissing J. Cycle ergometry is not a sensitive diagnostic test for mitochondrial myopathy. J Neurol. 2003;250:293-9. (Pubitemid 36399268)
28. Hicks JE, et al. Isometric exercises increases strength and does not produce sustained creatine phosphokinase in a patient with polymyositis. J Rheumatol. 1993;20:1399-401. (Pubitemid 23310999)
29. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol. 1993;20:1340-4. (Pubitemid 23310986)
30. Wiesinger GF, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol. 1998;37:196-200.
31. Wiesinger GF, et al. Benefit of 6-months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol. 1998;37:1338-42.
32. Heikkilä S, et al. Rehabilitation in myositis. Physiother. 2001;87:301-9.
33. Varjú C, et al. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil. 2003;17:83-7. (Pubitemid 36230983)
34. Kroll M, Otis J, Kagen L. Serum enzyme, myoglobin and muscle strength relationships in polymyositis and dermatomyositis. J Rheumatol. 1986;13:349-55. (Pubitemid 16034590)
35. Alexanderson H, Stenström CH, Lundberg IE. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford). 1999;38:608-11. (Pubitemid 29507327)
36. Alexanderson H, et al. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol. 2000;29:295-301. (Pubitemid 32014846)
37. Dastmalchi M, et al. Effect of physical training in proportion of slow-twitch type I muscle fibers. A novel non-immune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum. 2007;57:1303-10. (Pubitemid 47585478)
38. Chung YL, et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacological treatment: six-month double-blind randomized placebo-controlled trial. Arthritis Rheum. 2007;57:694-702.
39. Alexanderson H, et al. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum. 2007;57:768-77. (Pubitemid 46932082)
40. Rider LG, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum. 2004;50:2281-90. (Pubitemid 38924407)
41. •• Nader GA, et al.Alongitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol Med. 2010;16:455-64. This study suggests that resistance exercise may reduce inflammation and fibrosis in muscle tissue of patients with polymyositis and dermatomyositis in chronic, established disease.
42. • Omori C, et al. Responsiveness to exercise training in juvenile dermatomyositis: a twin case study. BMC Muskuloskeletal Dis. 2010;11:270. This case report is the only publication to describe tolerance of exercise over weeks to months in a patient with juvenile dermatomyositis.
43. Maillard SM, et al. Quantitative assessment of the effects of a single exercise session on muscles in juvenile dermatomyositis. Arthritis Rheum. 2005;53:558-64. (Pubitemid 41278920)
44. Takken T, et al. Responsiveness of exercise parameters in children with inflammatory myositis. Arthritis Rheum. 2008;59:59-64. (Pubitemid 351171879)
45. Takken T, et al. Aerobic capacity in patients with juvenile dermatomyositis. J Rheumatol. 2003;39:1075-80. (Pubitemid 36529634)
46. Takken T, van der Net J, Helders PJ. Anaerobic exercise capacity in patients with juvenile onset idiopathic inflammatory myopathies. Arthritis Rheum. 2005;53:173-7. (Pubitemid 40530156)
47. Long AR, Rouster-Stevens KA. The role of exercise therapy in the management of juvenile idiopathic arthritis. Curr Opin Rheumatol. 2010;22:213-7.